Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19

• The health care system in Bulgaria faces unprecedented challenges trying to take control over the pandemic of COVID-19. • The existing national regulation in Bulgaria leads to delayed and difficult access to investigational drugs via compassionate use programs. • The COVID-19 pandemic will initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzhafer, Nigyar, Papathanasiou, Jannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239779/
https://www.ncbi.nlm.nih.gov/pubmed/32837882
http://dx.doi.org/10.1016/j.hlpt.2020.05.001
_version_ 1783536746568351744
author Dzhafer, Nigyar
Papathanasiou, Jannis
author_facet Dzhafer, Nigyar
Papathanasiou, Jannis
author_sort Dzhafer, Nigyar
collection PubMed
description • The health care system in Bulgaria faces unprecedented challenges trying to take control over the pandemic of COVID-19. • The existing national regulation in Bulgaria leads to delayed and difficult access to investigational drugs via compassionate use programs. • The COVID-19 pandemic will initiate a dialogue among health policy makers and BDA for the establishment of new health policy and clear national regulation due to higher demand for investigational drugs.
format Online
Article
Text
id pubmed-7239779
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fellowship of Postgraduate Medicine. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72397792020-05-21 Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19 Dzhafer, Nigyar Papathanasiou, Jannis Health Policy Technol Article • The health care system in Bulgaria faces unprecedented challenges trying to take control over the pandemic of COVID-19. • The existing national regulation in Bulgaria leads to delayed and difficult access to investigational drugs via compassionate use programs. • The COVID-19 pandemic will initiate a dialogue among health policy makers and BDA for the establishment of new health policy and clear national regulation due to higher demand for investigational drugs. Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. 2020-09 2020-05-21 /pmc/articles/PMC7239779/ /pubmed/32837882 http://dx.doi.org/10.1016/j.hlpt.2020.05.001 Text en © 2020 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dzhafer, Nigyar
Papathanasiou, Jannis
Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title_full Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title_fullStr Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title_full_unstemmed Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title_short Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19
title_sort compassionate drug use: an imperative challenge for bulgarian health system during covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239779/
https://www.ncbi.nlm.nih.gov/pubmed/32837882
http://dx.doi.org/10.1016/j.hlpt.2020.05.001
work_keys_str_mv AT dzhafernigyar compassionatedruguseanimperativechallengeforbulgarianhealthsystemduringcovid19
AT papathanasioujannis compassionatedruguseanimperativechallengeforbulgarianhealthsystemduringcovid19

Ejemplares similares